Olive Diagnostics launches AI-powered urinalysis device so you don’t have to pee in a cup
But Israeli medical device startup Olive Diagnostics has come up with a way to use artificial intelligence to analyze what’s in your toilet bowl — so you don’t have to pee in a cup.
The Jerusalem-based company uses an optical sensor and AI-powered device to perform 100% passive real-time urine analysis. And it is extending its seed funding round to $7.3 million, after raising an additional $1.5 million from existing investors and private investors.
The investors in the pre-seed stage include Israeli HMO Maccabi Healthcare Services, Mayo Clinic, eHealth Ventures, Amgen Ventures, The Israel Innovation Authority, alongside private European and American private investors.
Olive Diagnostics was founded in 2019 by CEO Guy Goldman and Corey Katz. The startup’s team includes experts in biochemistry, chemistry, physics, data analytics, optics, and business development for the health and wellness markets.
Olive Diagnostics’ flagship product, Olive KG, is the world’s first AI- and spectroscopy-based device, which performs high-quality analysis of important parameters in the patients’ urine in each urination, in a 100% passive way and without any need for additional accessories. (Yes, no pee cups).
